FibroDynamx is a drug discovery company developing therapies that promote tissue regeneration, without scarring. The platform is based on our Regenerative Blueprint, which combines proprietary data from our reindeer model with human wound healing data. FibroDynamx's first product (FD-001, a protein-based drug) prevents scar formation, and improves skin regeneration 10-fold in animal models of skin injury.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.fibrodynamx.com
- Keywords
- Vancouver.
Fibrodynamx Questions
Fibrodynamx's website is http://www.fibrodynamx.com
Fibrodynamx's LinkedIn profile is https://www.linkedin.com/company/fibrodynamx
Fibrodynamx's industry is
Biotechnology Research
Fibrodynamx's top competitors are
Axcell Labs,
Neuropeutics Inc,
Northern Vascular Systems Inc.,
Htuo Biosciences,
Phyco Technologies,
Primary Bioscience,
Northernmost,
Singularity Health,
Vivamed Inc.,
Traqc.
Fibrodynamx's categories are Biotechnology Research
Fibrodynamx's founding year is 2024
